Investor · Cambridge, MA

Sharon Shacham

Open Sharon in the network graph →

Filings

9

SEC Form D

Connections

31

co-filers

Capital

$117.5M

across filings

Active

Nov 2010

to Feb 2026

Most-connected co-filers (31)

Mansoor R. Mirza · Newton, MA3 shared Marcin Czernik · Cambridge, MA2 shared Kristina Masson · Cambridge, MA2 shared Peter Blume-Jensen · Cambridge, MA2 shared Sunil Madhu · Jersey City, NJ2 shared Kenneth Weg · Cambridge, MA2 shared Richard Butera · Pittsburgh, PA2 shared Stephen P. Harrington · Plymouth Meeting, PA2 shared Barry E. Greene · Newton, MA2 shared Ryan Morton · Ann Arbor, MI2 shared Patrick Senatore · Ann Arbor, MI2 shared Fady Harfoush · Naperville, IL2 shared Michael C. Kauffman · NEEDHAM, MA2 shared Eric J. Devroe · Wakefield, MA2 shared Udi Gilboa · TEL AVIV, L31 shared Michael Kauffman · Natick, MA1 shared Lynda Chin · Houston, TX1 shared David Silberman · TEL AVIV, L31 shared Deepika R. Pakianathan · Mountain View, CA1 shared Mansoor R. Mirza · Salt Lake City, UT1 shared Isaac Israel · Tel Aviv, L31 shared Dan Teleman · NESS ZIONA, L31 shared Erick Gamelin · Watertown, MA1 shared Raju Kucherlapati · Weston, MA1 shared

Recent filings (9)

Nasus Pharma LtdFeb 2026 · 7 co-filers$15.0M Regenimo Biosciences, Inc.Nov 2025 · 5 co-filers$2.0M Regenimo Biosciences, Inc.Nov 2025 · 5 co-filers$2.0M Acrivon Therapeutics, Inc.Nov 2021 · 13 co-filers$100.0M Acrivon Therapeutics, Inc.Nov 2021 · 13 co-filers$100.0M Acrivon Therapeutics, Inc.Feb 2021 · 9 co-filers$15.5M Acrivon Therapeutics, Inc.Feb 2021 · 9 co-filers$15.5M Karyopharm Therapeutics Inc.Aug 2013 · 13 co-filers$19.0M Karyopharm Therapeutics Inc.May 2013 · 11 co-filers$60.0M Devonian Acquisition CorpApr 2013 · 1 co-filer$2.1M Devonian Acquisition CorpMar 2013 · 1 co-filer$11.7M Karyopharm Therapeutics Inc.Nov 2010 · 5 co-filers$20.8M Karyopharm Therapeutics Inc.Nov 2010 · 5 co-filers$20.8M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Sharon in the interactive graph →